{"product_id":"orasure-business-model-canvas","title":"OraSure Technologies Business Model Canvas","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eBusiness Model Canvas Preview - Strategic Blueprint for Diagnostics Growth\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eUnlock the strategic blueprint behind OraSure Technologies with our concise Business Model Canvas preview — see how value propositions, partnerships, and revenue streams connect to drive growth. Dive into market positioning, regulatory advantages, and scaling levers that investors and founders need. Download the full Word\/Excel canvas for a section-by-section, actionable roadmap you can use for benchmarking and strategy.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eP\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eartnerships\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eHealthcare providers \u0026amp; clinics\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003ePrimary care clinics, sexual health centers and community health organizations deploy OraSure point-of-care tests, driving recurring demand amid an estimated 1.2 million people living with HIV in the US (CDC). Clinical partners supply real-world feedback on usability, sensitivity and workflow integration, supporting pilots and population screening initiatives. Joint education and training programs increase adoption and improve outcomes. Founded 1988, OraSure leverages these networks for product iteration.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePublic health agencies \u0026amp; NGOs\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003ePartnerships with CDC-backed programs, ministries of health and NGOs expand access to HIV and infectious disease testing, targeting the estimated 38.4 million people living with HIV globally (UNAIDS 2023). These stakeholders fund screening campaigns and bulk purchases—often covering millions of tests annually—and support inclusion of OraSure assays in national guidelines and reimbursement pathways. Data-sharing feeds national surveillance and WHO reporting, enabling measurement of program impact and test uptake.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDistributors \u0026amp; pharmacy chains\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eNational distributors and retail pharmacy networks (over 20,000 US pharmacy locations across CVS, Walgreens and Walmart) extend OraSure’s OTC and professional channel reach and handle last-mile logistics, shelf space and in-store promotions. Co-marketing agreements and planogram optimization with chains boost sell-through and inventory turnover. Regional distributors enable faster international market penetration across Europe and Latin America.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eRegulatory \u0026amp; standards bodies\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eCollaboration with FDA, EMA\/CE and standards groups secures compliant pathways and faster market entry; FDA 510(k) median review was about 89 days in 2024, helping OraSure pace launches. Pre-submission meetings materially de-risk clinical strategy and reduce review cycles. Post-market surveillance frameworks and CLIA-waiver\/OTC alignment sustain quality and broaden addressable markets.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eRegulatory partners: FDA, EMA\/CE, standards bodies\u003c\/li\u003e\n\u003cli\u003e2024 FDA 510(k) median review ~89 days\u003c\/li\u003e\n\u003cli\u003ePre-sub meetings reduce review cycles\u003c\/li\u003e\n\u003cli\u003eCLIA-waiver\/OTC alignment expands TAM\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eResearch institutions \u0026amp; OEM partners\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eUniversities, CROs, and biotech partners co-develop assays and validate novel specimen types, giving OraSure access to external expertise and clinical validation channels. OEM and white-label agreements embed OraSure collection kits into broader diagnostic workflows, extending commercial reach through partner sales forces. Research collaborators provide cohorts and datasets while joint IP development accelerates pipeline expansion and technology licensing.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eCo-development with academic\/CRO partners\u003c\/li\u003e\n\u003cli\u003eOEM\/white-label distribution\u003c\/li\u003e\n\u003cli\u003eAccess to cohorts and datasets\u003c\/li\u003e\n\u003cli\u003eJoint IP accelerates pipeline\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePOC\/OTC HIV testing scaled by clinical, retail \u0026amp; NGO partners - \u003cstrong\u003e1.2M\u003c\/strong\u003e US, \u003cstrong\u003e20,000+\u003c\/strong\u003e locs\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eOraSure’s clinical, public-health and retail partners (primary care, sexual-health centers; \u0026gt;20,000 US pharmacy locations) drive recurring POC and OTC demand for assays amid ~1.2M US and 38.4M global people living with HIV (CDC; UNAIDS 2023). Regulatory and NGO linkages (FDA 510(k) median 89 days in 2024) speed market entry and scale screening campaigns. Academic\/CRO\/OEM collaborations accelerate validation, IP and distribution.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003ePartner type\u003c\/th\u003e\n\u003cth\u003eRole\u003c\/th\u003e\n\u003cth\u003e2024 metric\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eClinical\/Community\u003c\/td\u003e\n\u003ctd\u003ePOC deployment\u003c\/td\u003e\n\u003ctd\u003e1.2M US PLWH\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eRetail\/Distrib\u003c\/td\u003e\n\u003ctd\u003eOTC reach\u003c\/td\u003e\n\u003ctd\u003e20,000+ US locations\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eRegulatory\/NGO\u003c\/td\u003e\n\u003ctd\u003eMarket access\u003c\/td\u003e\n\u003ctd\u003eFDA 510(k) median 89d\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eA comprehensive, pre-written Business Model Canvas for OraSure Technologies that maps customer segments, channels, value propositions, revenue streams, key partners and activities across the 9 classic blocks; includes competitive advantages, SWOT-linked insights and actionable validation using real company data—ideal for presentations, funding discussions and strategic planning.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eHigh-level view of OraSure Technologies' business model that quickly identifies how diagnostic innovation, partnerships, and distribution address testing access and accuracy gaps—editable and shareable for rapid team alignment and decision-making.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eA\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003ectivities\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAssay R\u0026amp;D and validation\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eDesigning, optimizing and clinically validating rapid tests for infectious disease and substance abuse, with analytical and clinical studies commonly involving hundreds to thousands of specimens to support regulatory filings. Iterative improvements target sensitivity \u0026gt;95% and specificity \u0026gt;98% while simplifying use. Pipeline prioritization is data-driven, aligning with epidemiology and customer demand across top pathogen categories.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eManufacturing \u0026amp; quality control\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eScaled production of lateral-flow test kits and molecular collection devices is performed under GMP and ISO 13485 standards, with dedicated cleanrooms and validated processes to maintain regulatory compliance.\u003c\/p\u003e\n\u003cp\u003eIn-process testing and lot-release controls, including bioburden and functional assays, ensure batch-to-batch consistency and traceability across production runs.\u003c\/p\u003e\n\u003cp\u003eSupply planning models account for seasonality and public-health surges, coordinating raw material vendors and safety stock to prevent disruption.\u003c\/p\u003e\n\u003cp\u003eContinuous improvement initiatives, using lean and Six Sigma tools, target reductions in scrap and cycle times to improve yield and throughput.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eRegulatory affairs \u0026amp; compliance\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eRegulatory affairs manages submissions for CLIA-waived, OTC and professional-use indications globally, supporting OraSure (NASDAQ: OSUR) product portfolio and enabling market access across multiple regions. Continuous post-market surveillance, vigilance reporting and audits adhere to timelines (15-day serious incident reporting in the EU) and internal KPIs, driving corrective actions. Labeling, UDI and QMS maintenance align with IVDR and FDA requirements; regulatory engagement expedites label changes and indication expansions.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eCommercial sales \u0026amp; market access\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eField sales, distributor enablement, and provider education drive clinical adoption while HEOR evidence underpins reimbursement and guideline inclusion; contracting with GPOs and governments secures volume (GPOs influence ~90% of US hospital purchasing in 2024) and targeted digital marketing expands OTC awareness and e‑commerce reach.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eField sales\u003c\/li\u003e\n\u003cli\u003eDistributor enablement\u003c\/li\u003e\n\u003cli\u003eHealthcare education\u003c\/li\u003e\n\u003cli\u003eHEOR → reimbursement\/guidelines\u003c\/li\u003e\n\u003cli\u003eGPOs\/government contracts (~90% hospital reach)\u003c\/li\u003e\n\u003cli\u003eDigital marketing → OTC growth\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSupply chain \u0026amp; vendor management\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eOraSure sources membranes, reagents, plastics and packaging from qualified suppliers with dual-sourcing covering ~80% of critical components and safety stocks typically sized at 45–60 days to ensure supply continuity.\u003c\/p\u003e\n\u003cp\u003eCold-chain and hazardous-material logistics are coordinated through certified carriers and temperature-monitored lanes, while continuous cost and lead-time optimization efforts target ~20% lead-time reduction and ~200 bps gross-margin improvement.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eDual-sourcing ~80% of critical parts\u003c\/li\u003e\n\u003cli\u003eSafety stocks 45–60 days\u003c\/li\u003e\n\u003cli\u003e20% lead-time reduction target\u003c\/li\u003e\n\u003cli\u003e~200 bps gross-margin uplift goal\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGMP\/ISO 13485 rapid diagnostics: \u003cstrong\u003e80%\u003c\/strong\u003e dual-sourcing, 90% GPO reach\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eDesign, GMP\/ISO 13485 manufacture and clinical validation of rapid diagnostics; QA\/lot-release, global regulatory submissions and post-market vigilance (15-day EU SI reporting), supply planning with dual-sourcing ~80% and 45–60 days safety stock, sales\/distribution via GPOs (~90% hospital reach), CI targets: −20% lead-time, ~200 bps gross-margin uplift.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003e2024\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eDual-sourcing\u003c\/td\u003e\n\u003ctd\u003e~80%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSafety stock\u003c\/td\u003e\n\u003ctd\u003e45–60 days\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eGPO reach\u003c\/td\u003e\n\u003ctd\u003e~90%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCI targets\u003c\/td\u003e\n\u003ctd\u003e−20% LT \/ ~200 bps\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003eFull Version Awaits\u003c\/span\u003e\u003cbr\u003e Business Model Canvas\u003c\/h2\u003e\n\u003cp\u003eThe document you're previewing is the actual OraSure Technologies Business Model Canvas, not a mockup or sample. When you purchase, you’ll receive this exact file—fully formatted and complete—in editable Word and Excel versions. No surprises, ready to present and use immediately.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"PortersFiveForce","offers":[{"title":"Default Title","offer_id":55674852901241,"sku":"orasure-business-model-canvas","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0914\/5276\/8633\/files\/orasure-business-model-canvas.png?v=1755796808","url":"https:\/\/portersfiveforce.com\/products\/orasure-business-model-canvas","provider":"Porter's Five Forces","version":"1.0","type":"link"}